VEGF, VEGFR2 and GSTM1 polymorphisms in outcome of multiple myeloma patients treated with thalidomide-based regimens
Sign Up to like & getrecommendations! Published in 2017 at "Blood Cancer Journal"
DOI: 10.1038/bcj.2017.58
Abstract: VEGF , VEGFR2 and GSTM1 polymorphisms in outcome of multiple myeloma patients treated with thalidomide-based regimens read more here.
Keywords: polymorphisms outcome; vegfr2 gstm1; vegf vegfr2; multiple myeloma ... See more keywords